ADVB
Advanced BiomedยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ADVB
Advanced Biomed Inc.
A biotechnology company dedicated to the research and development of advanced microfluidic bio chip technology
Healthcare Equipment and Supplies
07/16/2021
03/06/2025
NASDAQ Stock Exchange
31
06-30
Common stock
No.689-85 Xiaodong Road, Yongkang District, Tainan City, Taiwan
--
Advanced Biomed Inc., was incorporated in Nevada on July 16, 2021. They operate through Advanced Biomed Inc. and Advanced Biomed HK Limited. Advanced Biomed Taiwan is responsible for the operation and design development of the company's main technologies and products. Since their inception in 2014, they have focused on integrating multiple interdisciplinary technologies and have established their own microfluidic technology platform. Using the physical and molecular biological properties of tumor cells, a variety of advanced original research has been developed through the combined application of semiconductor technology and biotechnology. Advanced Biotech HK is their first localized operation company, mainly responsible for market operation and management in China, localized production, product registration, and future sales of their products in the local market in accordance with relevant Chinese regulations.
Company Financials
EPS
ADVB has released its 2025 Q4 earnings. EPS was reported at -0.03, versus the expected 0, missing expectations. The chart below visualizes how ADVB has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
